



| 货号 | 包装规格 | 操作 |
|---|---|---|
| SML0883-5MG | 5 mg |
≥98%(HPLC)
HIF-2α拮抗剂。
Hypoxia inducible transcription factors (HIF) control gene expression when oxygen availability is low and are associated with the onset and progression of a variety of cancers. They are heterodimers of an HIF-α (HIF-1α, HIF-2α also known as EPAS-1, or HIF-3α) and aryl hydrocarbon receptor nuclear translocator (ARNT, also known as HIF-β). N-(3-Chloro-5-fluorophenyl)-4-nitrobenzo[c][1,2,5]oxadiazol-5-amine is a highly selective antagonist of HIF-2 heterodimerization, DNA-binding activity, and target gene transcription. It binds the HIF-2α PAS-B domain with a KD ~80 nM compared to a KD > 5000 nM for the HIF-1α PAS-B domain.
该化合物是基因调控研究的特色产品。单击此处了解更多特色基因调控产品。在sigma.com/discover-bsm了解更多用于其他研究领域的生物活性小分子。
| 英文名称 | HIF-2 Antagonist 2 |
| CAS 号 | 1422955-31-4 |
| 经验分子式 | C12H6ClFN4O3 |
| 分子量 | 308.65 |
| UNSPSC | 12352200 |
| NACRES | NA.77 |
| SMILES字符串 | Fc1cc(cc(c1)Nc2c(c3n[o]nc3cc2)[N+](=O)[O-])Cl |
| InChI | 1S/C12H6ClFN4O3/C13-6-3-7(14)5-8(4-6)15-10-2-1-9-11(17-21-16-9)12(10)18(19)20/h1-5,15H |
| InChI key | 捷克共和国 |
| 含量测定 | ≥98%(HPLC) |
| 形态 | 粉末 |
| 颜色 | 白色至米色 |
| 溶解性 | DMSO:15 mg/mL,澄清 |
| 储存温度 | 室温 |
| 质量等级 | 100 |
| 包装规格(货号 SML0883-5MG) | 5 mg |